Safety and mutagenicity evaluation of nanoparticulate red mold rice

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 22, 2008, Pages 11038-11048

  Yu, Chiun Chieh ^a   Wang, Jyh Jye ^b   Lee, Chun Lin ^a   Lee, Shu Hui ^c   Pan, Tzu Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAJEN UNIVERSITY   (Taiwan)

^c FISHERIES RESEARCH INSTITUTE   (Taiwan)

Author keywords

Monascus; Mutagenicity; Nanoparticulate; Safety

Indexed keywords

MUTAGENIC AGENT; PLANT EXTRACT;

ANIMAL; ARTICLE; CHEMISTRY; DIET; FEMALE; FERMENTATION; FOOD HANDLING; MALE; METABOLISM; METHODOLOGY; MICROBIOLOGY; MONASCUS; MUTAGEN TESTING; PARTICLE SIZE; PLANT SEED; RAT; RICE; WISTAR RAT;

ANIMALS; DIET; FEMALE; FERMENTATION; FOOD HANDLING; MALE; MONASCUS; MUTAGENICITY TESTS; MUTAGENS; ORYZA SATIVA; PARTICLE SIZE; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS;

MONASCUS; RATTUS; SALMONELLA TYPHIMURIUM;

EID: 57849128977     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf801335u     Document Type: Article

References (56)

1. Su, Y. C.; Chen, W. L.; Lee, Y. H. Studies on the anka pigment product by a mutant of Monascus anka. Mem. Coll. Agric., Natl. Taiwan Univ. 1973, 14, 41-56 (in Chinese).
2. Li, C. L.; Zhu, Y.; Wang, Y. Y.; Zhu, J. S.; Chang, J.; Kritchevsky, D. Monascus purpureus-fermented rice (red yeast rice): A natural food product that lowers blood cholesterol in animal models of hypercholesterolemia. Nutr. Res. (N.Y.) 1998, 18, 71-81.
3. Su, Y. C.; Wang, J. J.; Lin, T. T.; Pan, T. M. Production of the secondary metabolites γ-aminobutyric acid and monacolin K by Monascus. J. Ind. Microbiol. Biotechnol. 2003, 30, 41-46.
4. Heber, D.; Yip, I.; Ashley, J. M.; Elashoff, D. A.; Elashoff, R. M.; Go, V. L. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am. J. Clin. Nutr. 1999, 69, 231-236.
5. Endo, A. Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J. Antibiot. (Tokyo) 1979, 32, 852-854.
6. Kohama, Y.; Matsumoto, S.; Mimura, T.; Tanabe, N.; Inada, A.; Nakanishi, T. Isolation and identification of hypotensive principles in red-mold rice. Chem. Pharm. Bull (Tokyo) 1987, 35, 2484-2489.
7. Aniya, Y.; Yokomakura, T.; Yonamine, M.; Nagamine, T.; Nakanishi, H. Protective effect of the mold Monascus anka against acetaminophen-induced liver toxicity in rats. Jpn. J. Pharmacol. 1998, 78, 79-82.
8. Kitabatake, N.; Doi, E.; Trivedi, A. B. Toxicity evaluation of the mycotoxins, citrinin and ochratoxin A, using several animal cell lines. Comp. Biochem. Physiol. C. 1993, 105, 429-433.
9. Blanc, P. J.; Laussac, J. P.; Le Bars, J.; Le Bars, P.; Loret, M. O.; Pareilleux, A.; Prome, D.; Prome, J. C.; Santerre, A. L.; Goma, G. Characterization of monascidin A from Monascus as citrinin. Int. J. Food Microbiol. 1995, 27, 201-213.
10. Kitabatake, N.; Trivedi, A. B.; Doi, E. Thermal decomposition and detoxification of citrinin under various moisture conditions. J. Agric. Food Chem. 1991, 39, 2240-2244.
11. Fouler, S. G.; Trivedi, A. B.; Kitabatake, N. Detoxification of citrinin and ochratoxin A by hydrogen peroxide. J. AOAC Int. 1994, 77, 631-637.
12. Wang, J. J.; Lee, C. L.; Pan, T. M. Modified mutation method for screening low citrinin-producing strains of Monascus purpureus on rice culture. J. Agric. Food Chem. 2004, 52, 6977-6982.
13. Lee, C. L.; Chen, W. P.; Wang, J. J.; Pan, T. M. A simple and rapid approach for removing citrinin while retaining monacolin K in red mold rice. J. Agric. Food Chem. 2007, 55, 11101-11108.
14. Trivedi, A. B.; Doi, E.; Kitabatake, N. Toxic compounds formed on prolonged heating of citrinin under watery conditions. J. Food Sci. 1993, 58, 229-232.
15. Yu, C. C.; Lee, C. L.; Pan, T. M. A novel formulation approach for preparation of nanoparticulate red mold rice. J. Agric. Food Chem. 2006, 54, 6845-6851.
16. Salata, O. V. Applications of nanoparticles in biology and medicine. J. Nanobiotechnol. 2004, 2, 3.
17. Muller, R. H.; Jacobs, C.; Kayser, O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv. Drug Delivery Rev. 2001, 47, 3-19.
18. Merisko-Liversidge, E.; Liversidge, G. G.; Cooper, E. R. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci. 2003, 18, 113-120.
19. Hoet, P. H.; Bruske-Hohlfeld, I.; Salata, O. V. Nanoparticles - known and unknown health risks. J. Nanobiotechnol. 2004, 2, 12.
20. Donaldson, K.; Stone, V.; Tran, C. L.; Kreyling, W.; Borm, P. J. Nanotoxicology. Occup. Environ. Med. 2004, 61, 727-728.
21. Jia, X.; Li, N.; Chen, J. A subchronic toxicity study of elemental nano-Se in Sprague-Dawley rats. Life Sci. 2005, 76, 1989-2003.
22. Lee, C. L.; Hung, H. K.; Wang, J. J.; Pan, T. M. Improving the ratio of monacolin K to citrinin production of Monascus purpureas NTU 568 under dioscorea medium through the mediation of pH value and ethanol addition. J. Agric. Food Chem. 2007, 55, 6493-6502.
23. Pecora, R. Dynamic light scattering measurement of nanometer particles in liquids. J. Nanopart. Res. 2000, 2, 123-131.
24. Lee, C. L.; Wang, J. J.; Pan, T. M. Synchronous analysis method for detection of citrinin and the lactone and acid forms of monacolin K in red mold rice. J. AOAC Int. 2006, 89, 669-677.
25. Sabater-Vilar, M.; Maas, R. F. M.; Fink-Gremmels, J. Mutagenicity of commercial Monascus fermentation products and the role of citrinin contamination. Mutat. Res. 1999, 444, 7-16.
26. Liu, B. H.; Wu, T. S.; Su, M. C.; Chung, C. P.; Yu, F. Y. Evaluation of citrinin occurrence and cytotoxicity in Monascus fermentation products. J. Agric. Food Chem. 2005, 53, 170-175.
27. Ames, B. N.; McCann, J.; Yamasaki, E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 1975, 31, 347-364.
28. OECD Guidelines for the Testing of Chemicals Test 471: Bacterial Reverse Mutation Test; OECD: Paris, France, adopted 1997; http://masetto.sourceoecd.org/vl=3461816/cl=11/nw=1/rpsv/cw/vhosts/oecdjournals/ 1607310x/v1n4/contp1-1.htm.
29. OECD Guidelines for the Testing of Chemicals Test 407: Repeated Dose 28-Day Oral Toxicity Study in Rodents; OECD: Paris, France, adopted 1995; http://miranda.sourceoecd.org/vl=382735/cl=15/nw=1/rpsv/cw/vhosts/oecdjournals/ 1607310x/v1n4/contp1-1.htm.
30. OECD Guidelines for the Testing of Chemicals Test 408: Repeated Dose 90-Day Oral Toxicity Study in Rodents; OECD: Paris, France, adopted 1998; http://miranda.sourceoecd.org/vl=382735/cl=15/nw=1/rpsv/cw/vhosts/oecdjournals/ 1607310x/v1n4/contp1-1.htm.
31. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies J. Nutr. 1977, 107, 1340-1348.
32. Baseline Hematology and Clinical Chemistry Values for Charles River Wistar Rats [Crl:(WI)BR] as a Function of Sex and Age; Charles River Laboratories, Inc.: Wilmington, MA, 1998; http://www.criver.com/en-US/ProdServ/ ByType/ResModOver/Pages/On-lineLiterature.aspx.
33. Olfert, E. D.; Cross, B. M.; McWilliam, A. A. Guide to the Care and Use of Experimental Animals; Canadian Council on Animal Care: Ottawa, Canada, 1993; http://www.ccac.ca/en/CCAC_Programs/Guidelines_Policies/PDFs/ ExperimentalAnimals_GDL.pdf.
34. Merisko-Liversidge, E.; Sarpotdar, P.; Bruno, J.; Hajj, S.; Wei, L.; Peltier, N.; Rake, J.; Shaw, J. M.; Pugh, S.; Polin, L.; Jones, J.; Corbett, T.; Cooper, E.; Liversidge, G. G. Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm. Res. 1996, 13, 272-278.
35. Merisko-Liversidge, E.; McGurk, S. L.; Liversidge, G. G. Insulin nanoparticles: a novel formulation approach for poorly water soluble Zn-insulin. Pharm. Res. 2004, 21, 1545-1553.
36. Farber, B. Y.; Graves, G. A. Ceramic media with improved efficiency. PCI 2001, (April), 30-41.
37. Mortelmans, K.; Zeiger, E. The Ames Salmonella/microsome mutagenicity assay. Mutat. Res. 2000, 455, 29-60.
38. Levin, D. E.; Hollstein, M.; Christman, M. F.; Schwiers, E. A.; Ames, B. N. A new Salmonella tester strain (TA102) with A-T base pairs at the site of mutation detects oxidative mutagens. Proc. Natl. Acad. Sci. U.S.A. 1982, 79, 7445-7449.
39. Wang, J. J.; Shieh, M. J.; Kuo, S. L.; Lee, C. L.; Pan, T. M. Effect of red mold rice on antifatigue and exercise-related changes in lipid peroxidation in endurance exercise. Appl. Microbiol. Biotechnol. 2006, 70, 247-253.
40. Lee, C. L.; Kuo, T. F.; Wang, J. J.; Pan, T. M. Red mold rice ameliorates impairment of memory and learning ability in intracerebroventricular amyloid beta-infused rat by repressing amyloid beta accumulation. J. Neurosci. Res. 2007, 85, 3171-3182.
41. Downs, J. R.; Clearfield, M.; Weis, S.; Whitney, E.; Shapiro, D. R.; Beere, P. A.; Langendorfer, A.; Stein, E. A.; Kruyer, W.; Gotto, A. M., Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA - J. Am. Med. Assoc. 1998, 279, 1615-1622.
42. MacDonald, J. S.; Gerson, R. J.; Kornbrust, D. J.; Kloss, M. W.; Prahalada, S.; Berry, P. H.; Alberts, A. W.; Bokelman, D. L. Preclinical evaluation of lovastatin. Am. J. Cardiol. 1988, 62, 16J-27J.
43. Kornbrust, D. J.; MacDonald, J. S.; Peter, C. P.; Duchai, D. M.; Stubbs, R. J.; Germershausen, J. I.; Alberts, A. W. Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits. J. Pharmacol. Exp. Ther. 1989, 248, 498-505.
44. MEVACOR product information; Merck & Co., Inc., Whitehouse Station, NJ, 1996; http:// www.fda.gov/cder/foi/label/2002/19643s067lbl.pdf.
45. Jordan, W. H.; Carlton, W. W.; Sansing, G. A. Citrinin mycotoxicosis in the mouse. Food Cosmet. Toxicol. 1977, 15, 29-34.
46. Jordan, W. H.; Carlton, W. W.; Sansing, G. A. Citrinin mycotoxicosis in the Syrian hamster. Food Cosmet. Toxicol. 1978, 16, 355-363.
47. Hanika, C.; Carlton, W. W.; Tuite, J. Citrinin mycotoxicosis in the rabbit. Food Cosmet. Toxicol. 1983, 21, 487-493.
48. Wang, J. J.; Pan, T. M. Effect of red mold rice supplements on serum and egg yolk cholesterol levels of laying hens. J. Agric. Food Chem. 2003, 51, 4824-4829.
49. Wang, J. J.; Pan, T. M.; Shieh, M. J.; Hsu, C. C. Effect of red mold rice supplements on serum and meat cholesterol levels of broilers chicken. Appl. Microbiol. Biotechnol. 2006, 71, 812-818.
50. Su, Y. C.; Huang, T. L. Animal feeding test for Monascus pigment. Mem. College Agric., Natl. Taiwan Univ. 1981, 21, 98-112 (in Chinese).
51. Cicero, A. F. G.; Brancaleoni, M.; Laghi, L.; Donati, F.; Mino, M. Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: a pilot study. Complem. Ther. Med. 2005, 13, 273-278.
52. Li, Z.; Seeram, N. P.; Lee, R.; Thames, G.; Minutti, C.; Wang, H. J.; Heber, D. Plasma clearance of lovastatin versus Chinese red yeast rice in healthy volunteers. J. Altern. Complement Med. 2005, 11, 1031-1038.
53. Health Food Control Act; Department of Health, Taipei, Taiwan, 1999; http://food.doh.gov.tw/english/Acts_Regulations/Healthfood_1.asp?lawsidx=417.
54. Dose Calculator, U.S. Food and Drug Administration http://www.fda.gov/ cder/cancer/animalframe.htm.
55. McCarthy, M. FDA bans red yeast rice product. Lancet 1998, 351, 1637.
56. Havel, R. J. Dietary supplement or drug? The case of cholestin. Am. J. Clin. Nutr. 1999, 69, 175-176.